Arylamino Esters As P‐Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity

Publisher： John Wiley & Sons Inc

E-ISSN： 1860-7187|10|8|1339-1343

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.10, Iss.8, 2015-08, pp. : 1339-1343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydrophobic moments as physicochemical descriptors in structure-activity relationship studies of P-glycoprotein inhibitors

By König Gerhard  

Monatshefte für Chemie / Chemical Monthly, Vol. 139, Iss. 4, 2008-04 ,pp. : 401-405

Springer Publishing Company

Access to resources Recommend Favorite

Intestinal P‐glycoprotein inhibitors, benzoxanthone analogues

By  

JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol. 70, Iss. 2, 2018-02 ,pp. : 234-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modulation of Multidrug Resistance in Cancer Cells by Inhibitors of P-Glycoprotein

By Safa Ahmad R.  

CHIMIA International Journal for Chemistry, Vol. 53, Iss. 6, 1999-06 ,pp. : 299-299

Swiss Chemical Society

Access to resources Recommend Favorite

Helenalin Analogues Targeting NF‐κB p65: Thiol Reactivity and Cellular Potency Studies of Varied Electrophiles

By  

CHEMMEDCHEM, Vol. 13, Iss. 4, 2018-02 ,pp. : 303-311

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design of Fexofenadine Prodrugs Based on Tissue‐Specific Esterase Activity and Their Dissimilar Recognition by P‐Glycoprotein

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 3076-3083

John Wiley & Sons Inc

Access to resources Recommend Favorite